Metraipolis › archive › dc_9ebccd2a0dc4
Transfer and Metabolism of the Xenoestrogen Zearalenone in Human Perfused Placenta — Europe PMC PMID:31596610
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31596610
- DOI
- 10.1289/ehp4860
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-10T08:56:44.615Z
- SHA-256 of the archived text
35bcd0983b845669a140906f0fa4a7d6f720b052a69156e77096361df6f0010d- Stable URL of this page
https://metraipolis.com/documento/dc_9ebccd2a0dc4
How to cite
Transfer and Metabolism of the Xenoestrogen Zearalenone in Human Perfused Placenta — Europe PMC PMID:31596610 — Europe PMC (en), https://europepmc.org/article/MED/31596610 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_9ebccd2a0dc4 (Metraipolis archive dc_9ebccd2a0dc4, sha256 35bcd0983b845669a140906f0fa4a7d6f720b052a69156e77096361df6f0010d)
BibTeX
@misc{dc9ebccd2a0dc4,
title = {Transfer and Metabolism of the Xenoestrogen Zearalenone in Human Perfused Placenta — Europe PMC PMID:31596610},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31596610},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_9ebccd2a0dc4; sha256 35bcd0983b845669a140906f0fa4a7d6f720b052a69156e77096361df6f0010d},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31596610. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Pregnancy is a sensitive condition during which adverse environmental exposures should be monitored thoroughly and minimized whenever possible. In particular, the hormone balance during gestation is delicate, and disturbance may cause acute or chronic long-term health effects. A potential endocrine disruption may be provoked by in utero exposure to xenoestrogens mimicking endogenous estrogens. The mycoestrogen zearalenone (ZEN), a toxic fungal secondary metabolite and mycotoxin found frequently in food and feed, constitutes a prominent example. Objectives: We performed a comprehensive assessment of the transfer as well as phase I and phase II metabolism of ZEN at the human placental barrier. Methods: Human placentas were perfused with 1μM (318μg/L) ZEN for 6 h. Samples from the maternal and fetal compartment, placental tissue, and fetal plasma were analyzed by a highly sensitive UHPLC-MS/MS assay to detect ZEN as well as nine key metabolites (α-zearalenol, β-zearalenol, zearalanone, α-zearalanol, β-zearalanol, ZEN-14-glucuronide, α-zearalenol-14-glucuronide, β-zearalenol-14-glucuronide, ZEN-14-sulfate). Results: The model revealed a fast maternofetal transfer of ZEN across the human placental barrier. We also unraveled phase I and phase II metabolism of the parent toxin ZEN into the approximately 70-times more estrogenic α-zearalenol and the less active ZEN-14-sulfate conjugate, which are effectively released into the maternal and fetal circulation in considerable amounts. Conclusions: Our findings suggest that exposure to ZEN (such as through consumption of ZEN-contaminated cereal-based products) during pregnancy may result in in utero exposure of the fetus, not only to ZEN but also some of its highly estrogenically active metabolites. In the light of the known affinity of ZEN and potentially co-occurring xenoestrogens to the estrogen receptor, and our results demonstrating placental transfer of ZEN and its metabolites in an ex vivo model, we recommend further research and more comprehensive assessment of gestational exposures in women. https://doi.org/10.1289/EHP4860. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2019 (prima pubblicazione 2019-10-09). Identificativi: PMID 31596610 · PMCID PMC6867367 · DOI 10.1289/ehp4860. Pagina: https://europepmc.org/article/MED/31596610 — https://doi.org/10.1289/ehp4860. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-10T08:52:00.069Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.